The major factors for the growth of the European diagnostic imaging equipment market include the increase in the geriatric population and the rising prevalence of chronic diseases, technological advancement in imaging modalities, and the rising adoption of medical imaging devices.
The increase in the geriatric population and the rising prevalence of chronic diseases is one of the major factors boosting the growth of the market. According to the estimates of the World Aging Report 2017, published by the United Nations, in Germany, approximately 28.0% of the population was aged 60 years and over, in 2017. This percentage is expected to become 37.6%, by 2050. Furthermore, as per the data published by the Office for National Statistics, around 18.2% of the population in the United Kingdom was aged 65 years or over, in mid-2017, and this is projected to grow to 20.7% by 2027. Thus, the rising aging population is expected to increase the prevalence of various chronic diseases, resulting in the high demand for medical imaging devices.
For instance, according to the estimates of the Globocan, in 2018, there were 446,942 new cancer cases in the United Kingdom. Prostate, breast, lung, colon, and skin cancers are the most common types of cancers detected in the United Kingdom. Hence all these factors have helped the growth of the diagnostic imaging equipment market in Europe, and is expected to boost the growth in the region in future as well.
Key Market Trends
Application in Oncology is Expected to Witness the Fastest Growth over the Forecast Period
Diagnostic imaging plays a vital role in interventional oncology (with rising opportunities to diagnose and treat in a targeted and minimally or non-invasive manner) as well as in chemo and radiation therapy. The tools, such as CT, are the highly beneficial and preferred method of imaging for many conditions, including trauma patients. Comparatively, PET is mostly preferred as compared to SPECT, and there are hybrid medical devices also available such as PET/CT or PET/MRI.
The use is expected to increase in the future due to the increasing incidence of cancer in Europe. As per a 2018 study by the International Agency for Research on Cancer, there were nearly 4.2 million cases of cancer in 2018, which is expected to increase to more than 4.8 million by 2030. This will increase the demand for diagnostic imaging equipment, which will boost the market growth in the region.
Competitive Landscape
The market studied is a fragmented one, owing to the presence of various players. Some of the market players are Canon Medical Systems Corporation, Carestream Health Inc., Esaote SpA, FUJIFILM Holdings Corporation, GE Healthcare, Hitachi Medical Systems, Hologic Corporation, Koninklijke Philips NV, Shimadzu Medical, and Siemens Healthineers.
Reasons to Purchase this report:
The increase in the geriatric population and the rising prevalence of chronic diseases is one of the major factors boosting the growth of the market. According to the estimates of the World Aging Report 2017, published by the United Nations, in Germany, approximately 28.0% of the population was aged 60 years and over, in 2017. This percentage is expected to become 37.6%, by 2050. Furthermore, as per the data published by the Office for National Statistics, around 18.2% of the population in the United Kingdom was aged 65 years or over, in mid-2017, and this is projected to grow to 20.7% by 2027. Thus, the rising aging population is expected to increase the prevalence of various chronic diseases, resulting in the high demand for medical imaging devices.
For instance, according to the estimates of the Globocan, in 2018, there were 446,942 new cancer cases in the United Kingdom. Prostate, breast, lung, colon, and skin cancers are the most common types of cancers detected in the United Kingdom. Hence all these factors have helped the growth of the diagnostic imaging equipment market in Europe, and is expected to boost the growth in the region in future as well.
Key Market Trends
Application in Oncology is Expected to Witness the Fastest Growth over the Forecast Period
Diagnostic imaging plays a vital role in interventional oncology (with rising opportunities to diagnose and treat in a targeted and minimally or non-invasive manner) as well as in chemo and radiation therapy. The tools, such as CT, are the highly beneficial and preferred method of imaging for many conditions, including trauma patients. Comparatively, PET is mostly preferred as compared to SPECT, and there are hybrid medical devices also available such as PET/CT or PET/MRI.
The use is expected to increase in the future due to the increasing incidence of cancer in Europe. As per a 2018 study by the International Agency for Research on Cancer, there were nearly 4.2 million cases of cancer in 2018, which is expected to increase to more than 4.8 million by 2030. This will increase the demand for diagnostic imaging equipment, which will boost the market growth in the region.
Competitive Landscape
The market studied is a fragmented one, owing to the presence of various players. Some of the market players are Canon Medical Systems Corporation, Carestream Health Inc., Esaote SpA, FUJIFILM Holdings Corporation, GE Healthcare, Hitachi Medical Systems, Hologic Corporation, Koninklijke Philips NV, Shimadzu Medical, and Siemens Healthineers.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
1 INTRODUCTION
4 MARKET DYNAMICS
5 MARKET SEGMENTATION
6 COMPETITIVE LANDSCAPE
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Canon Medical Systems Corporation
- Carestream Health Inc.
- Esaote SpA
- FUJIFILM Holdings Corporation
- GE Healthcare
- Hitachi Medical Systems
- Hologic Corporation
- Koninklijke Philips NV
- Shimadzu Medical
- Siemens Healthineers
Methodology
LOADING...
